Risk of bacterial vaginosis among women with herpes simplex virus type 2 infection: A systematic review and meta-analysis

Journal of Infectious Diseases

Volumn 212, Issue 1, 2015, Pages 8-17

  Esber, Allahna ^a   Vicetti Miguel, Rodolfo D ^b   Cherpes, Thomas L ^b   Klebanoff, Mark A ^b,d   Gallo, Maria F ^a   Turner, Abigail Norris ^c  

^a Georgia Department of Public Health   (United States)

^b Department of Microbial Infection and Immunity ^*  (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^d THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Bacterial vaginosis; herpes simplex virus type 2; meta analysis; systematic review.

Indexed keywords

CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HERPES SIMPLEX VIRUS 2 INFECTION; HUMAN; INFECTION RISK; LONGITUDINAL STUDY; META ANALYSIS; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SENSITIVITY ANALYSIS; SEROPREVALENCE; SYSTEMATIC REVIEW; VAGINITIS; COMPLICATION; GENITAL HERPES; RISK ASSESSMENT; VAGINOSIS, BACTERIAL;

FEMALE; HERPES GENITALIS; HUMANS; RISK ASSESSMENT; VAGINOSIS, BACTERIAL;

EID: 84936804372     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv017     Document Type: Review

References (48)

1. Hillier SL, Marrazzo JM, Holmes KK. Bacterial vaginosis. In: Holmes KK, Sparling PF, Stamm WE, Piot P, eds. Sexually transmitted diseases. New York: McGraw-Hill, 2008.
2. Amsel R, Totten P, Spiegel C, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74: 14-22.
3. Nugent R, Krohn M, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29:297-301.
4. Oleen-Burkey M, Hillier S. Pregnancy complications associated with bacterial vaginosis and their estimated costs. Infect Dis Obstet Gynecol 1995; 157:149-57.
5. Cohen CR, Lingappa JR, Baeten JM, et al. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med 2012; 9:e1001251.
6. Bradshaw C, Morton A, Garland S, et al. Higher-risk behavioral practices associated with bacterial vaginosis compared with vaginal candidiasis. Obstet Gynecol 2005; 106:105-14.
7. Hawes SE, Hillier SL, Benedetti J, et al. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis 1996; 174: 1058-63.
8. Yotebieng M, Turner AN, Hoke TH, et al. Effect of consistent condom use on 6-month prevalence of bacterial vaginosis varies by baseline BV status. Trop Med Int Health 2009; 14:480-6.
9. Ness RB, Hillier SL, Richter HE, et al. Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina. Obstet Gynecol 2002; 100:765.
10. Van De Wijgert JH, Mason PR, Gwanzura L, et al. Intravaginal practices, vaginal flora disturbances, and acquisition of sexually transmitted diseases in Zimbabwean women. J Infect Dis 2000; 181:587-94.
11. Ness RB, Hillier S, Richter HE, et al. Can known risk factors explain racial differences in the occurrence of bacterial vaginosis? J Natl Med Assoc 2003; 95:201-12.
12. Allsworth J, Peipert J. Prevalence of bacterial vaginosis: 2001-2004 national health and nutrition examination survey data. Obstet Gynecol 2007; 109:114-20.
13. CDC. Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years-United States, 2005-2008. MMWR Morb Mortal Wkly Rep 2010; 59:456-9.
14. Cherpes TL, Hillier SL, Meyn LA, et al. A delicate balance: risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive herpes simplex virus type 2 serology. Sex Transm Dis 2008; 35:78-83.
15. Kaul R, Nagelkerke NJ, Kimani J, et al. Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections. J Infect Dis 2007; 196:1692-7.
16. Schiffer JT, Corey L. Rapid host immune response and viral dynamics in herpes simplex virus-2 infection. Nat Med 2013; 19:280-90.
17. Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp. Accessed 16 December 2014.
18. Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-60.
19. Nagot N, Ouedraogo A, Defer M-C, et al. Association between bacterial vaginosis and Herpes simplex virus type-2 infection: implications for HIV acquisition studies. Sex Transm Infect 2007; 83:365-8.
20. Atashili J, Poole C, Ndumbe PM, et al. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 2008; 22: 1493-501.
21. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2008.
22. Begg C, Mazumdar M. Operating characteristics of a bank correlation test for publication bias. Biometrics 1994; 50:1088-101.
23. Egger M, Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-34.
24. Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 1999; 47:15-7.
25. Schwebke J, Hillier S. Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. Obstet Gynecol 1996; 88:573-6.
26. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009; 6:e1000100.
27. Allsworth JE, Lewis VA, Peipert JF. Viral sexually transmitted infections and bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Sex Transm Dis 2008; 35:791-6.
28. Chawla R, Bhalla P, Bhalla K. Community-based study on seroprevalence of herpes simplex virus type 2 infection in New Delhi. Indian J Med Microbiol 2008; 26:34-9.
29. Cherpes TL, Meyn LA, Krohn MA, et al. Risk factors for infection with herpes simplex virus type 2: role of smoking, douching, uncircumcised males, and vaginal flora. Sex Transm Dis 2003; 30:405-10.
30. Evans B, Kell PD, Bond R, et al. Predictors of seropositivity to herpes simplex virus type 2 in women. Int J STD AIDS 2003; 14:30-6.
31. Kapiga S, Sam N, Masenga E. Risk factors for bacterial vaginosis among bar and hotel workers in Northern Tanzania. East African Med J 2005; 82:85-91.
32. Kirakoya-Samadoulougou F, Nagot N, Defer M-C, et al. Epidemiology of herpes simplex virus type 2 infection in rural and urban Burkina Faso. Sex Transm Dis 2011; 38:117-23.
33. Kirakoya-Samadoulougou F, NagotN, Defer M-C, et al. Bacterial vaginosis among pregnant women in Burkina Faso. Sex Transm Dis 2008; 35:985-9.
34. Madhivanan P, Krupp K, Chandrasekaran V, et al. Prevalence and correlates of bacterial vaginosis among young women of reproductive age in Mysore, India. Indian J Med Microbiol 2008; 26:132-7.
35. Riedner G, Hoffmann O, Rusizoka M, et al. Decline in sexually transmitted infection prevalence and HIV incidence in female barworkers attending prevention and care services in Mbeya Region, Tanzania. AIDS 2006; 20:609-15.
36. Uma S, Balakrishnan P, Murugavel K. Bacterial vaginosis in women of low socioeconomic status living in slum areas in Chennai, India. Sex Health 2006; 3:297-8.
37. Uma S, Balakrishnan P, Murugavel K. Bacterial vaginosis in female sex workers in Chennai, India. Sex Health 2005; 2:261-2.
38. Wang J, Zhu Z, Yang X, et al. Herpes simplex virus type 2 risks in female sex workers in the China-Vietnam border county of Hekou. Biomed Env Sci 2012; 25:706-10.
39. Msuya S, Mbizvo E, Hussain A, et al. Seroprevalence and correlates of herpes simplex virus type 2 among urban Tanzanian women. Sex Transm Dis 2003; 30:588-92.
40. Masese L, Baeten JM, Richardson BA, et al. Incident herpes simplex virus type 2 infection increases the risk of subsequent episodes of bacterial vaginosis. J Infect Dis 2014; 209:1023-7.
41. Brotman R, Ravel J, Cone R, et al. Rapid fluctuation of the vaginal microbioata measured by Gram stain analysis. Sex Transm Infect 2010; 86:297-302.
42. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0. Cochrane Collab 2011; 51.
43. Moher D, Pham B, Lawson M, et al. The inclusion of reports of randomised trials published in languages other than English in systematic reviews. Heal Technol Assess 2003; 7:1-90.
44. Cherpes TL, Melan MA, Kant JA, et al. Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization. Clin Infect Dis 2005; 40:1422-8.
45. Baeten J, Hassan W. Prospective study of correlates of vaginal Lactobacillus colonisation among high-risk HIV-1 seronegative women. Sex Transm Infect 2009; 85:348-53.
46. Stoner KA, Reighard SD, Vicetti Miguel R, et al. Recalcitrance of bacterial vaginosis among HSV-2 seropositive women. J Obs Gynaecol Res 2012; 38:77-83.
47. Ya W, Reifer C, Miller LE. Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebocontrolled study. Am J Obstet Gynecol 2010; 203:120e1-6.
48. Bradshaw CS, Tabrizi SN, Fairley CK, et al. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy. J Infect Dis 2006; 194:828-36.